US Patent 8012960 Heterocyclic aspartyl protease inhibitors
Patent 8012960 was granted and assigned to Schering on September, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+55 characters)
Article
Patent abstract
Disclosed are compounds of the formula I
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08012960 Heterocyclic aspartyl protease inhibitors US Patent 8012960 Heterocyclic aspartyl protease inhibitors
Infobox
Patent Number
0801296000
Patent Number
801296000
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080129600
Date of Patent
September 6, 2011
0Patent Application Number
127948580
Date Filed
June 7, 2010
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080129600
Date of Patent
September 6, 2011
0Patent Application Number
127948580
Date Filed
June 7, 2010
0Patent Primary Examiner
Edits on 13 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08012960 Heterocyclic aspartyl protease inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08012960
Date of patent
September 6, 2011
Patent application number
12794858
Date Filed
June 7, 2010
Patent primary examiner
Find more entities like US Patent 8012960 Heterocyclic aspartyl protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
